Axena Health
PrivateLast Round
Early Stage
VC
Dec 19, 2025
Total Funding Raised
$43.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Axena Health operates in Healthcare & Life Sciences and is based in Newton, Massachusetts. Its latest recorded funding round was a Series A Extension round in June 2024.
Axena Health is a medical device company that provides an innovative platform for the non-invasive, drug-free treatment of urinary and chronic fecal incontinence, helping women improve their pelvic floor health through real-time movement visualization and progress monitoring.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Telemedicine, Patient Engagement
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Axena Health Comparables
Compare Axena Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Materna Medical | 82% | |
| Renalis Health | 79% | |
| Junofem | 78% |
For institutional investors. Book with your work email.
Axena Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Dec 19, 2025 | ||||
| Series A Extension | Jun 4, 2024 | ||||
| Series A | Feb 16, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Axena Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOFA Healthcare | Series A, Series A Extension |
| AXA IM Alts | Series A Extension, Series A |
| Avestria Ventures | Series A Extension, Series A |
| Cross Border Impact Ventures | Series A, Series A Extension |
| BNP Paribas Asset Management | Series A Extension, Series A |
| AXA Investment Managers | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 61% MoM, reaching 5.9K.
- Jan 14, 2026
New AI solution for women with pelvic floor disorders.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 20, 2026
On Oct 20th '26, the Digital Health Hub Foundation recognizes Axena Health, Inc. as a finalist in the Best in Class Track for Women's and Family Health at the Digital Health & AI Awards 2026 at HLTH, selected from more than 1,300 participating companies.
- recognized_asOct 20, 2026
Axena Health, Inc. is selected as a finalist in the Digital Health Hub Awards’ Best in Class Track for Women’s and Family Health from more than 1,300 submissions across all tracks and categories.
- attends_eventOct 20, 2026
Representatives from Axena Health, Inc. attend HLTH USA in United States in Nov '26 to connect with healthcare leaders, clinicians, and industry innovators and discuss expanding access to evidence-based treatment for pelvic floor disorders.
For institutional investors. Book with your work email.
Axena Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Axena Health's valuation, stock price, and market status.
Is Axena Health a public or private company?
Axena Health is a private company.
What is the current stock price of Axena Health?
Axena Health is a private company, so its shares have no public market price. Caplight tracks Axena Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Axena Health worth (valuation)?
Valuation information for Axena Health is not publicly available.
Can I buy Axena Health stock?
Axena Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Axena Health's last funding round?
Axena Health's most recent funding round was Early Stage VC on December 19, 2025.
Who are the main investors in Axena Health?
Key investors in Axena Health include AXA IM Alts, Cross Border Impact Ventures, BNP Paribas Asset Management.
Will Axena Health IPO soon?
No public IPO plans have been announced for Axena Health.
How can I track Axena Health secondary market activity?
Caplight tracks bids, offers, and trades in Axena Health's shares on secondary markets.